Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$4.56 - $8.78 $7,948 - $15,303
-1,743 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$4.8 - $5.89 $1,536 - $1,884
-320 Reduced 15.51%
1,743 $9,000
Q2 2019

Aug 12, 2019

BUY
$4.72 - $5.88 $9,737 - $12,130
2,063 New
2,063 $11,000

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $282M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.